News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,049 Results
Type
Article (87310)
Company Profile (759)
Press Release (770953)
Multimedia
Podcasts (166)
Webinars (27)
Section
Business (233003)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91223)
Employer Resources (202)
FDA (18262)
Job Trends (17392)
News (397272)
Policy (39910)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (139)
Alzheimer's disease (1661)
Antibody-drug conjugate (ADC) (212)
Approvals (18266)
Artificial intelligence (466)
Autoimmune disease (53)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (155)
Biotechnology (484)
Bladder cancer (120)
Brain cancer (47)
Breast cancer (454)
Cancer (3649)
Cardiovascular disease (323)
Career advice (3552)
Career pathing (36)
CAR-T (236)
CDC (52)
Cell therapy (644)
Cervical cancer (31)
Clinical research (75082)
Collaboration (1320)
Company closure (4)
Compensation (878)
Complete response letters (57)
COVID-19 (2946)
CRISPR (80)
C-suite (525)
Cystic fibrosis (130)
Data (3981)
Decentralized trials (2)
Denatured (59)
Depression (106)
Diabetes (438)
Diagnostics (7067)
Digital health (31)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (226)
Drug pricing (171)
Drug shortages (36)
Duchenne muscular dystrophy (188)
Earnings (98667)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132549)
Executive appointments (964)
FDA (20571)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1172)
Gene editing (167)
Generative AI (45)
Gene therapy (511)
GLP-1 (1006)
Government (5359)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (35)
IgA nephropathy (54)
Immunology and inflammation (232)
Immuno-oncology (19)
Indications (50)
Infectious disease (3172)
Inflammatory bowel disease (180)
Inflation Reduction Act (14)
Influenza (89)
Intellectual property (175)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (73)
Layoffs (631)
Leadership (32)
Legal (10147)
Liver cancer (91)
Longevity (12)
Lung cancer (522)
Lymphoma (252)
Machine learning (25)
Management (66)
Manufacturing (594)
MASH (125)
Medical device (14844)
Medtech (14862)
Mergers & acquisitions (22696)
Metabolic disorders (1111)
Multiple sclerosis (132)
NASH (23)
Neurodegenerative disease (201)
Neuropsychiatric disorders (54)
Neuroscience (2616)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (55)
Obesity (549)
Opinion (305)
Ovarian cancer (122)
Pain (158)
Pancreatic cancer (156)
Parkinson's disease (223)
Partnered (28)
Patents (395)
Patient recruitment (281)
Peanut (57)
People (66116)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23145)
Phase II (32609)
Phase III (24538)
Pipeline (2554)
Policy (285)
Postmarket research (3554)
Preclinical (10450)
Press Release (72)
Prostate cancer (185)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (628)
Real estate (7418)
Recruiting (78)
Regulatory (27809)
Reports (64)
Research institute (2680)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (68)
Schizophrenia (123)
Series A (194)
Series B (145)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (97)
Tariffs (85)
The Weekly (105)
Vaccines (1020)
Venture capital (64)
Weight loss (384)
Women's health (57)
Worklife (21)
Date
Today (111)
Last 7 days (556)
Last 30 days (2354)
Last 365 days (33800)
2025 (24588)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50855)
Australia (8933)
California (9075)
Canada (2766)
China (860)
Colorado (384)
Connecticut (405)
Delaware (249)
Europe (116821)
Florida (1335)
Georgia (307)
Hawaii (3)
Idaho (67)
Illinois (794)
India (47)
Indiana (445)
Iowa (19)
Japan (289)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (76)
Maryland (1231)
Massachusetts (6822)
Michigan (302)
Minnesota (550)
Mississippi (4)
Missouri (114)
Montana (33)
Nebraska (26)
Nevada (105)
New Hampshire (76)
New Jersey (2510)
New Mexico (32)
New York (2477)
North Carolina (1376)
North Dakota (10)
Northern California (4048)
Ohio (285)
Oklahoma (19)
Oregon (50)
Pennsylvania (1890)
Puerto Rico (19)
Rhode Island (45)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3465)
Tennessee (145)
Texas (1416)
United States (33640)
Utah (270)
Virginia (240)
Washington D.C. (82)
Washington State (783)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
There are 859,049 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cell X Technologies and BioLamina enter a collaboration to advance standardization in iPSC-based therapeutics
September 29, 2025
·
3 min read
Press Releases
TAE Life Sciences Novel Boronated Drugs for BNCT in Combination with Immune Checkpoint Inhibitors Demonstrate Superior Tumor Growth Inhibition in Preclinical in vivo Models
September 29, 2025
·
2 min read
Press Releases
Spur® Elute DEEPER CORONARY Study Completes Enrollment
September 29, 2025
·
3 min read
Press Releases
Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by Ministry of Health, Labour and Welfare of Japan
September 29, 2025
·
5 min read
Press Releases
Accendatech’s Phase 3 Trial of ACT001, an Oral Compound with Novel MoA, Begins Enrolling Patients with Small Cell Lung Cancer with Brain Metastasis in a Highly Competitive Research Field
September 29, 2025
·
2 min read
Press Releases
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
September 29, 2025
·
11 min read
Press Releases
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
September 29, 2025
·
1 min read
Press Releases
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
September 29, 2025
·
4 min read
Press Releases
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 29, 2025
September 29, 2025
·
2 min read
Press Releases
ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy®
September 29, 2025
·
13 min read
1 of 85,905
Next
